Over the past three years, GLP-1 receptor agonists (this is the class of drugs that includes Ozempic, Wegovy, and Mounjaro) have transformed how doctors and patients approach weight management.
*The services provided have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. The material on this website is provided for informational purposes only and is not medical advice. Always consult your physician before beginning any therapy program. All therapies are specific formulations prepared by REVIV. Any designations or references to therapies are for marketing purposes only and do not represent actual products
© REVIV 2026
*The services provided have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. The material on this website is provided for informational purposes only and is not medical advice. Always consult your physician before beginning any therapy program. All therapies are specific formulations prepared by REVIV. Any designations or references to therapies are for marketing purposes only and do not represent actual products
© REVIV 2026